Clinical trial Recruiting at 1 site Interventional Ages 5 to 12

Task-oriented circuit training to improve mobility and daily activity in children with hemiplegic cerebral palsy

Official title: Effects of Task Oriented Circuit Training on Functional Mobility and Activity Participation in Cerebral Palsy

Run by Foundation University Islamabad · NCT07275528 · Data updated 2026-11-12

This trial tests whether a structured, high-intensity circuit of task-specific exercises can help children (ages 5–12) with hemiplegic cerebral palsy walk farther and take part more in daily activities.

Quick facts

Study typeInterventional
Ages5 Years to 12 Years
SexAll
Enrollment34 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Islamabad)
StatusRecruiting
StartedSeptember 13, 2025
Main results expectedDecember 10, 2025
Study endsJanuary 10, 2026
Registry record updatedDecember 10, 2025
Trial IDNCT07275528 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5–12 with hemiplegic cerebral palsy, GMFCS level I or II, and mild spasticity (Modified Ashworth Scale grade 1–2) without major sensory, cognitive, or recent surgical interventions are ideal candidates.

Probably not a fit

Children with significant cognitive, visual, or hearing impairments, uncontrolled seizures, recent botulinum toxin injection (within 6 months), recent lower-extremity surgery, or major musculoskeletal/structural deformities are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a non-blinded randomized controlled trial enrolling 34 children with hemiplegic cerebral palsy (GMFCS I–II) who will be randomly assigned to task-oriented circuit training or conventional physical therapy. The intervention consists of 40–50 minute sessions, three times per week for eight consecutive weeks, delivered at a single center. Functional mobility will be measured with the 6-minute walk test and activity participation with the Child Engagement in Daily Life measurement scale at baseline, 4 weeks, and 8 weeks. Randomization uses sealed envelopes and the study is conducted at Foundation University/Fauji Foundation Hospital in the Islamabad/Rawalpindi area.

Why it matters

Potential benefit: If successful, this approach could increase walking endurance and improve participation in daily activities for children with hemiplegic cerebral palsy.

How similar studies have gone: Previous small trials of task-specific and circuit-based training in pediatric cerebral palsy have shown promising but modest improvements in motor function and participation, though larger trials are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed cases of hemiplegic cerebral palsy
* Both genders are included
* The children were between 5 and 12 years old.
* Their motor function was at a level I or II based on the GMFCS,
* The degree of spasticity grade 1 to 2 based on the Modified Ashworth Scale.

Exclusion Criteria:

* Visual or hearing loss
* Cognitive impairment
* Seizures
* A botulinum toxin injection in the previous six months,
* Lower extremity surgery
* Musculoskeletal disorders
* Structural deformities in the spine and/or lower limbs.

Where it's running

  • Foundation University College of Physical Therapy
    Islamabad, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.